The U.K. Medicines and Healthcare products Regulatory Agency MHRA has created a GCP Discussion Forum to help all those involved in the conduct of clinical trials implement quality procedures that can ensure compliance with clinical trials legislation and GCP requirements.

The platform also provides the ideal opportunity for an extended communication between researchers and allows users to put forward their comments and get 'real-life' examples.

Related GMP News
16/05/2012	Development and Manufacturing of APIs: Final ICH Q11 Document Published!
16/05/2012	Which Information on Stability of Pharmaceutical Bulk Products is required in the Application Dossier?
16/05/2012	EMA strengthens Oversight on Clinical Trials outside EU
16/05/2012	EMA - Regulatory procedural Advice on similar biological medicines
09/05/2012	The new EMA's eSubmission Gateway for Centralised Authorisations is released!